InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by Shah Gaurav, Chief Executive Officer. Director active across 1 companies, notably Rocket Pharmaceuticals, INC.. Cumulatively, 4 filings have been published. Total volume traded: €683k. The latest transaction was filed on 13 May 2026 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
US$8,3962,728 shares@ US$3.07780.0024% mcap2.5% of flow
Common Stock
SEC:0001140361-26-021315·
€8,3962,728 shares@ €3.07780.0024% mcap1.2% of flow
Common Stock
SEC:0001140361-26-021315:0·
€333,04922,000 shares@ €15.13860.094% mcap48.8% of flow
Common Stock
SEC:0001140361-22-004209:0·
Ideal exit: 4 Nov 2022 (T+270)
€333,04922,000 shares@ €15.13860.094% mcap97.5% of flow
Common Stock
SEC:0001140361-22-004209·
Ideal exit: 4 Nov 2022 (T+270)
4 of 4 declarations
About Shah Gaurav
Gaurav Shah is the CEO of Rocket Pharmaceuticals, Inc. He leads the company in its strategic and operational activities, focusing on innovation in gene therapies. His expertise in the biopharmaceutical sector is essential for guiding the growth and development of Rocket Pharmaceuticals.
